Scholars Central

Conference abstractPublished 26 Jun 2013

Studies on immune response against a new bicistronic DNA vaccine for anthrax using the protective antigen gene (pag) and catalytically inactivated lethal factor gene (mlef)

Authors: Bincy Joseph

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Anthrax is primarily a disease of herbivorous animals including cattle, buffalo, sheep, and goat. Anthrax causes per acute death in the animals, hence treatment is neither possible nor pragmatic approach to control the disease. So vaccination is considered as a key strategy for prevention and control of anthrax in ruminants. In the present study, bicistronic DNA vaccine construct for anthrax using protective antigen (pag) and catalytically inactivated mutated lethal factor (mlef) along with monocistronic construct encoding pag and mlef were developed. The lethal factor was catalytically inactivated by mutating the GAA codon to TGC codon (E687C) by primer based site directed mutagenesis. Simultaneously both pag and mlef were cloned and expressed in prokaryotic expression system and recombinant protein was used for booster immunization. Prepared DNA vaccine constructs were tested for their functional expression by transfection of MDBK cell line followed by indirect immune- fluorescence analysis. The immune response study was done in mice with these DNA vaccines boosted with DNA vaccine or recombinant protein or anthrax spore vaccine on 14 th and 28 th DPV and monitoring of immune response was done by ELISA. Antibodies were detectable from 7 th day onwards and peaked on 42 nd day. Cell mediated immune response was assessed by quantitating level of IFN γ , IL-2 and IL-4. The level of these three cytokines were high in the (pMlef-Pag+ rPag+ rMlef) and (pPag +rPag) groups. The immunized mice were challenged with 1000 LD 50 of Bacillus anthracis IVRI strain on 42 nd day. Among the various vaccine groups, pMlef-Pag+rPag+rMlef and pPag+rPag groups were found to provide maximum protection (66.66%) while, pMlef-Pag + pMlef-Pag, pPag+pPag and AVA induced only 50%, 33.33%, and 50% protection respectively. Considering the protective efficacy, immune responses and stimulation of cytokines pMlef- pPag+rPag+rMlef vaccine seems to be better than other vaccines. Among the DNA vaccine group pMlef-Pag had shown better immune response and protective efficacy than pPag indicating synergestic effect of pMlef on immune response and protective efficacy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Biotechnology & Biomaterials.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Biotechnology & Biomaterials
  • SubjectBiochemistry & Biotechnology
  • SubjectMaterials Science
  • BylineArticles whose byline prints “Bincy Joseph”